ADENOSINE
ADENOSINE INJECTION, USP 6mg/2mL (3mg/mL) 2mL VIAL
Approved
Approval ID
fa6eb0f8-7c41-2e17-e053-6294a90ac8ca
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 28, 2023
Manufacturers
FDA
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ADENOSINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51662-1631
Application NumberANDA078686
Product Classification
M
Marketing Category
C73584
G
Generic Name
ADENOSINE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 28, 2023
FDA Product Classification
INGREDIENTS (3)
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ADENOSINEActive
Quantity: 3 mg in 1 mL
Code: K72T3FS567
Classification: ACTIB